SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Albert Einstein

PatientAlbert Einstein
Date of birth1956-03-14
IdentifiersMRN HR-ET012-SYN; SSN (made up) 000-12-6650
Document date2026-04-21
AuthorClementine Ward, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week follow-up: CT angiography results and vascular surgery consultation the same day. [S]

History of Present Illness

Mr. Einstein is a 70-year-old man with a 5.0 cm infrarenal abdominal aortic aneurysm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy, who returns four weeks after his first visit for the CT angiography results and is seen by vascular surgery on the same day. He has had no abdominal, back, or flank pain, fainting, or leg symptoms. He stopped smoking on his quit date a week after the first visit and has had no tobacco for three weeks. He wears the 14 mg patch daily and uses three or four lozenges a day, and he holds an empty, unlit pipe while he works, which he finds helps. He started losartan 50 mg and atorvastatin 40 mg four weeks ago without side effects; his home blood pressure readings average 134/80. The CT angiography two weeks ago showed a 5.2 cm fusiform infrarenal aneurysm with a 2.2 cm neck, calcified atheroma of the aorta and iliac arteries, thickening along the front of the aneurysm from the old wrapping, and no fluid around the aorta. [S]

ElementDetail
Aneurysm5.0 cm by ultrasound four weeks ago; 5.2 cm outer-wall diameter on CT angiography two weeks ago
SymptomsNone
TobaccoTobacco-free for three weeks; nicotine patch and lozenges
Blood pressureHome average 134/80 on amlodipine 5 mg and losartan 50 mg

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, fainting, or leg pain on walking
GastrointestinalNegativeNo abdominal pain
MusculoskeletalNegativeNo back pain; no muscle aches on atorvastatin
RespiratoryNegativeMorning cough easing since stopping smoking

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2025-05-20activeS
Losartan 50 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2026-03-24 to 2026-04-21completedS
Losartan 100 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2026-04-21activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet by mouth each eveningOral route2026-03-24activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet by mouth daily with foodOral route2026-04-21activeS
Nicotine 14 mg/24 hour transdermal patch, one patch dailyApply one new patch each morningTopical route2026-03-24 to 2026-07-14completedS
Nicotine 2 mg lozenge as needed for cravingsDissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a dayOral route2026-03-24 to 2026-09-22completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-21Body height172cmS
2026-04-21Body weight78.6kgS
2026-04-21Body mass index (BMI) [Ratio]26.6kg/m2S
2026-04-21Systolic blood pressure136mm[Hg]S
2026-04-21Diastolic blood pressure82mm[Hg]S
2026-04-21Heart rate70/minS
2026-04-21Respiratory rate14/minS
2026-04-21Body temperature36.6CelS
2026-04-21Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-21Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-04-21Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-04-21Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.74-1.35 mg/dLNormalS
2026-04-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M72mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS

Physical Exam

Vital signs recorded on 2026-04-21; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 78.6 kg
CardiovascularRegular rhythm at 70 per minute; blood pressure 136/82 mmHg
AbdomenPulsatile, non-tender mass above the umbilicus; healed midline scar

Problems

ProblemClinical statusVerificationCodeProvenance
Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair thresholdactiveconfirmed I71.43S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic.
Essential hypertensionactiveconfirmed I10S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources.
Nicotine dependence, pipe tobaccoactiveconfirmed F17.290S — Synthetic modern coding anchored to his documented pipe smoking.
Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiographyactiveconfirmed I70.0S — Synthetic finding on the baseline CT angiography.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingAneurysm diameter by duplex ultrasound (CT if views are poor)Every 6 months at 5.0 to 5.4 cm in men; yearly at 4.0 to 4.9 cmUp to date5.0 cm by duplex ultrasound four weeks ago; next scan due at six months
ImagingCT angiography for baseline anatomy and repair planningOnce at baseline; again when repair is consideredCompleted todayCT angiography two weeks ago reviewed: 5.2 cm outer-wall diameter, 2.2 cm neck with 30-degree angulation, calcified atheroma, wrap-related thickening, no periaortic fluid; suitable for endovascular repair if needed
ExaminationFemoral and popliteal arteries for a coexisting aneurysmOnce at diagnosisCompleted todayVascular surgery examined the femoral and popliteal arteries: normal pulses, no aneurysm felt; a popliteal duplex will be added to the six-month scan
ExaminationAneurysm symptoms and tenderness, with the emergency plan reviewedEvery visitCompleted todayNo pain, tenderness, or fainting; emergency plan and wallet card reviewed
ReferralVascular surgery review and shared decision on elective repairAt baseline, then at a threshold change or yearlyCompleted todaySeen today by vascular surgery: shared decision on thresholds, surveillance, and endovascular versus open repair recorded
ExaminationBlood pressure, target below 130/80Every visitCompleted today136/82 mmHg; above target; losartan increased
Self-managementHome blood pressure readingsBefore each visit while treatment is being adjustedCompleted todayHome average 134/80 over the past week
LaboratoryMetabolic panel (sodium, potassium, creatinine, eGFR)2 to 4 weeks after starting or changing losartan; then every 6 monthsCompleted todayFour weeks after starting losartan: sodium 139, potassium 4.6, creatinine 1.08 mg/dL, eGFR 72; repeat after the dose increase
LaboratoryLipid panel4 to 12 weeks after starting a statin; then yearlyDueAtorvastatin started four weeks ago; lipid panel due by twelve weeks after the start
LaboratoryALTOnce before a statin; then only with symptomsUp to date24 U/L before starting atorvastatin
LaboratoryHbA1cYearlyUp to date5.6 percent four weeks ago
LaboratoryUrine albumin-to-creatinine ratioYearlyUp to date14 mg/g four weeks ago
Medication safetyStatin adherence and muscle symptomsEvery visitCompleted todayTaking atorvastatin each evening; no muscle aches
Medication safetyLow-dose aspirin: indication and bleedingEvery visit while taking itCompleted todayStarted today for aortic atheroma; no history of ulcer or bleeding
Medication safetyMedication review: avoid fluoroquinolones and anti-inflammatory pain medicinesEvery visitCompleted todayNo fluoroquinolone or anti-inflammatory use; told to remind any prescriber about the aneurysm
Self-managementTobacco use and cessation support (5 A's, nicotine replacement)Every visitCompleted todayTobacco-free for three weeks; 14 mg patch and three or four lozenges a day
Examination12-lead ECGBaseline with hypertension; repeat as indicatedCompleted today12-lead ECG today, requested by vascular surgery and serving as the hypertension baseline: sinus rhythm at 70, normal intervals, no left ventricular hypertrophy or Q waves
ExaminationAnkle-brachial indexEvery 2 to 3 years at 65 or older or with a smoking historyDueNo ankle-brachial index on record; to be done with the six-month duplex scan
ExaminationEye examination for hypertensive retinopathyYearlyDueNo eye examination in two years; to be arranged at the wellness visit
ExaminationWeight and BMIEvery visitCompleted today78.6 kg; BMI 26.6

Goal progress:

Guideline basis: The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018); 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022); CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021)

Follow-up: Three-month review with the metabolic panel and home blood pressure readings. Duplex ultrasound at six months. Next scheduled visit 2026-07-14: three-month review: blood pressure, lipids on a statin, and smoking cessation. [S]